Security Reports > Arbutus Biopharma

Arbutus Biopharma
Data Breaches, Cyber Attacks and Security Report  ᛫ 
Last updated September 25, 2020

Arbutus Biopharma Security Rating

/ 950

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Arbutus Biopharma is implementing good security practices.

Company Information


About Arbutus Biopharma

Arbutus Biopharma Corporation is a publicly traded (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Vancouver, British Columbia and has research facilities in Warminster, Pennsylvania.

Data Breaches and Security News

Security Report for Arbutus Biopharma

Want a security rating for your organization?

This report shows a preliminary security rating for Arbutus Biopharma. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.

Get a deeper scan

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Arbutus Biopharma's security performance with other companies